Condition
Transurethral Resection of the Prostate
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Unknown1
Not Yet Recruiting1
Withdrawn1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07460518Phase 4Not Yet Recruiting
Tranexamic Acid for Bleeding Reduction During TURP Surgery
NCT07363681Not ApplicableRecruiting
Inhalational Agents Versus Dexmedetomidine for Maintenance of General Anesthesia
NCT06531655WithdrawnPrimary
Intradetrusor Botox at the Time of Transurethral Resection of the Prostate for Mixed Lower Urinary Tract Symptoms
NCT05913466Not ApplicableUnknown
Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar TURP
Showing all 4 trials